Clinical Roundup Microplastics are discovered in prostate tumors, NYU researchers present at ASCO GU February 27, 2026Vol.52 No.08
Clinical Roundup ROSELLA phase III trial of relacorilant in platinum-resistant ovarian cancer meets OS primary endpoint February 27, 2026Vol.52 No.08
Clinical Roundup Rybrevant Faspro + immunotherapy shows strong clinical benefit for recurrent or metastatic head-and-neck cancer February 27, 2026Vol.52 No.08
Clinical Roundup Adjuvant immunotherapy + hormone therapy may counteract immune-suppression in early-stage prostate cancer, Mayo-led study finds February 27, 2026Vol.52 No.08
Clinical Roundup American Heart Association tool measures heart disease risk in testicular cancer survivors February 27, 2026Vol.52 No.08
Clinical Roundup “Lock-and-key” chemistry platform may keep therapeutic drugs inactive until they reach a tumor, Syracuse-led study finds February 27, 2026Vol.52 No.08
Clinical Roundup Renal and cardiovascular risks persist decades after testicular cancer treatment February 27, 2026Vol.52 No.08
Clinical Roundup Androgen receptor alterations in bloodwork linked to poorer outcomes across therapies treating metastatic prostate cancer February 27, 2026Vol.52 No.08
Clinical Roundup Exercise during chemotherapy for breast cancer improves quality of life, Sylvester-led study finds February 27, 2026Vol.52 No.08
Clinical Roundup Follicular lymphoma may be curable with chemoimmunotherapy combo, data from 15-year trial suggests February 27, 2026Vol.52 No.08
